Eli Lilly LLY Short-term debt and current portion of long-term debt
Short-term debt and current portion of long-term debt at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:DebtCurrent.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's short-term debt and current portion of long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's short-term debt and current portion of long-term debt?
- Eli Lilly (LLY) reported short-term debt and current portion of long-term debt of $4B in Q1 2026.
- How has Eli Lilly's short-term debt and current portion of long-term debt changed year-over-year?
- Eli Lilly's short-term debt and current portion of long-term debt decreased by 0.4% year-over-year, from $4.02B to $4B.
- What is the long-term trend for Eli Lilly's short-term debt and current portion of long-term debt?
- Over 5 years (2020 to 2025), Eli Lilly's short-term debt and current portion of long-term debt has grown at a 185.0% compound annual growth rate (CAGR), from $8.7M to $1.64B.